<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-antibodies-09-00020">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudenko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Desheva</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Korovkin</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mironov</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rekstin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Grigorieva</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Donina</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gambaryan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Katlinsky</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)</article-title>
  <source>Influenza Other Respir. Viruses</source>
  <year>2008</year>
  <volume>2</volume>
  <fpage>203</fpage>
  <lpage>209</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1750-2659.2008.00064.x</pub-id>
  <pub-id pub-id-type="pmid">19453396</pub-id>
 </element-citation>
</ref>
